Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The dose-dependent effect of SOX9 and its incidence in colorectal cancer.

European journal of cancer (Oxford, England : 1990) - 1 Nov 2017

Prévostel Corinne, Blache Philippe

Abstract excerpt

A member of the Sry-related HMG-box family of transcription factors (SOX9) is a transcription factor that belongs to the superfamily of High Mobility Group (HMG) domain transcription factors. SOX9 is expressed in a variety of tissues, including as the intestinal epithelium, where it is now recognised as an important actor for homeostasis. Beside, a high level of SOX9 has recently been correlated with a good...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cellular Senescence
Share to Colorectal Neoplasms
Share to Epithelial Cells

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasm Recurrence, Local

Share to Neoplasm Staging

Share to Neoplastic Stem Cells

Share to SOX9 Transcription Factor

Share to Tumor Suppressor Proteins

Source

Identifiers

PMID: 28988015
DOI: 10.1016/j.ejca.2017.08.037

Genes

SOX9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The dose-dependent effect of SOX9 and its incidence in colorectal cancer.PMID 28988015Read ↗

Oncogenicity of the Developmental Transcription Factor Sox9Semantic proximity Read ↗

Analysis of SOX9 Expression in Colorectal CancerSemantic proximity Read ↗

SOX9 is an atypical intestinal tumor suppressor controlling the oncogenic Wnt/ß-catenin signaling.Semantic proximity Read ↗

Clinical Correlation of Transcription Factor SOX3 in Cancer: Unveiling Its Role in TumorigenesisSemantic proximity Read ↗

SOX9: an important factor in regulating breast cancerSemantic proximity Read ↗

SOX9 suppresses colon cancer via inhibiting epithelial-mesenchymal transition and SOX2 inductionSemantic proximity Read ↗

SOX9 directly regulates <i>IGFBP-4</i> in the intestinal epitheliumSemantic proximity Read ↗

Recurrent, truncating SOX9 mutations are associated with SOX9 overexpression, KRAS mutation, and TP53 wild type status in colorectal carcinoma.Semantic proximity Read ↗

SOX2 expression is regulated by BRAF and contributes to poor patient prognosis in colorectal cancer.Semantic proximity Read ↗

SOX9 promotes epithelial‑mesenchymal transition via the Hippo‑YAP signaling pathway in gastric carcinoma cellsSemantic proximity Read ↗

The SOX9-MMS22L Axis Promotes Oxaliplatin Resistance in Colorectal CancerSemantic proximity Read ↗

SOX9 Stem-Cell Factor: Clinical and Functional Relevance in CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.